DN-1289

N/A

Report date: 2022/12/06 14:53:41
NME

Base Information

Drug NameDN-1289
Drug Alias NameDN-1289
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase 12 inhibitorsMitogen-activated protein kinase kinase kinase 13 inhibitors
TargetsMitogen-activated protein kinase kinase kinase 12Mitogen-activated protein kinase kinase kinase 13
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDenali Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A